Dupilumab‐associated hypereosinophilia in patients treated for moderate‐to‐severe atopic dermatitis - Archive ouverte HAL Access content directly
Journal Articles Journal of the European Academy of Dermatology and Venereology Year : 2021

Dupilumab‐associated hypereosinophilia in patients treated for moderate‐to‐severe atopic dermatitis

(1) , (1) , (2) , (3) , (4) , (5) , (5) , (6) , (7) , (8) , (9) , (10) , (11) , (12) , (1)
1
2
3
4
5
6
7
8
9
10
11
12
Not file

Dates and versions

hal-03844087 , version 1 (08-11-2022)

Identifiers

Cite

P. Marcant, P. Balayé, R. Merhi, F. Jendoubi, A. Nosbaum, et al.. Dupilumab‐associated hypereosinophilia in patients treated for moderate‐to‐severe atopic dermatitis. Journal of the European Academy of Dermatology and Venereology, 2021, 35 (6), pp.e394-e396. ⟨10.1111/jdv.17177⟩. ⟨hal-03844087⟩
0 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More